Key result
ICDs reduce mortality by ~24% in non-ischaemic heart disease.
Why the study?
Arrhythmias and sudden cardiac death remain significant clinical challenges with complex substrates, risk stratification difficulties, and evolving prevention strategies requiring comprehensive evaluation.
No takes yet. Share an insight, caveat, or question.
Supports ICD use for primary prevention in non-ischaemic cardiomyopathy; extends randomized evidence to this population.
Thomas Felix Lüscher (2017) conducted an editorial in Arrhythmias and sudden cardiac death. Implantable cardioverter defibrillators reduced mortality by 24% in patients without ischaemic heart disease, as highlighted in this editorial summarizing recent advances in sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: